See more : Arca Continental, S.A.B. de C.V. (AC.MX) Income Statement Analysis – Financial Results
Complete financial analysis of Al-Razi Medical Co. (9572.SR) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Al-Razi Medical Co., a leading company in the Medical – Pharmaceuticals industry within the Healthcare sector.
- KalNorth Gold Mines Limited (CKGDF) Income Statement Analysis – Financial Results
- M.W. Trade SA (MWT.WA) Income Statement Analysis – Financial Results
- ST International Holdings Company Limited (8521.HK) Income Statement Analysis – Financial Results
- Egeplast Ege Plastik Ticaret ve Sanayi Anonim Sirketi (EPLAS.IS) Income Statement Analysis – Financial Results
- National Aerospace Fasteners Corporation (3004.TW) Income Statement Analysis – Financial Results
Al-Razi Medical Co. (9572.SR)
About Al-Razi Medical Co.
Al-Razi Medical Company supplies medical equipment in Saudi Arabia. The company sells hospital beds, steam and suction devices, inhalation devices, masks, needles, oxygen masks, water bladders, bandages, gloves, and ear piercings. It serves hospitals, clinics, medical centers, medical companies, and pharmacies. The company was founded in 1986 and is headquartered in Dammam, Saudi Arabia.
| Metric | 2023 | 2022 | 2021 |
|---|---|---|---|
| Revenue | 61.33M | 52.39M | 45.19M |
| Cost of Revenue | 47.26M | 38.84M | 33.98M |
| Gross Profit | 14.07M | 13.55M | 11.21M |
| Gross Profit Ratio | 22.95% | 25.87% | 24.81% |
| Research & Development | 0.00 | 0.00 | 0.00 |
| General & Administrative | 1.15M | 1.13M | 0.00 |
| Selling & Marketing | 1.77M | 1.67M | 0.00 |
| SG&A | 12.26M | 10.66M | 8.56M |
| Other Expenses | 0.00 | 151.86K | 0.00 |
| Operating Expenses | 12.26M | 10.66M | 8.56M |
| Cost & Expenses | 59.92M | 49.50M | 42.54M |
| Interest Income | 0.00 | 0.00 | 0.00 |
| Interest Expense | 475.06K | 300.60K | 595.08K |
| Depreciation & Amortization | 3.51M | 2.68M | 2.00M |
| EBITDA | 5.07M | 5.72M | 5.12M |
| EBITDA Ratio | 8.27% | 10.64% | 10.27% |
| Operating Income | 1.41M | 2.89M | 2.65M |
| Operating Income Ratio | 2.31% | 5.52% | 5.85% |
| Total Other Income/Expenses | -328.76K | -465.39K | -112.48K |
| Income Before Tax | 1.09M | 2.43M | 2.53M |
| Income Before Tax Ratio | 1.77% | 4.63% | 5.61% |
| Income Tax Expense | 399.74K | 410.72K | 370.15K |
| Net Income | 685.97K | 2.01M | 2.16M |
| Net Income Ratio | 1.12% | 3.84% | 4.79% |
| EPS | 0.45 | 1.33 | 1.42 |
| EPS Diluted | 0.45 | 1.33 | 1.42 |
| Weighted Avg Shares Out | 1.52M | 1.52M | 1.52M |
| Weighted Avg Shares Out (Dil) | 1.52M | 1.52M | 1.52M |
Source: https://incomestatements.info
Category: Stock Reports